Health Tech World

Avante has raised US$30m in Series A funding to expand its AI-powered employee benefits platform internationally and develop automated AI agents. 🔗 Full story: buff.ly/xr9R8Oe #HealthTech #EmployeeBenefits #HealthcareAI #SeriesAFunding #DigitalHealth

An AI-heavy Budget has been broadly welcomed across the health technology sector, but industry leaders are clear that the test will be whether any of it reaches the frontline. 🔗 Full story: buff.ly/Bpryh8Y #AutumnBudget2026 #HealthcareAI #NHS #DigitalHealth #HealthTech

Unanswered questions after appointments can add to anxiety and contribute to repeat calls, people stopping medicines and avoidable hospital visits, a report warns. 🔗 Full story: buff.ly/wALXOgu #DigitalHealth #PatientSafety #HealthcareAI #PatientEmpowerment #HealthTech

Could gaps in your IP paperwork hold up a funding round? From undocumented know-how to unclear contractor agreements, routine oversights can cause last-minute problems during investor due diligence. Writing for Health Tech World, Elliot Stephens, Patent Director at HGF, explains three common pitfalls and how founders can address them before raising investment. 🔗 Full story: buff.ly/zPU1LMi #IntellectualProperty #StartupFunding #PatentLaw #HealthTech #InvestmentReadiness

Health tech company Feedback has secured a £127,000 NHS contract extension and a further £249,000 to develop its Bleepa clinical collaboration platform. 🔗 Full story: buff.ly/06vyHx7 #HealthTech #DigitalHealth #NHS #Bleepa #HealthcareInnovation

Could reducing admin help the NHS keep its people? Writing for Health Tech World, Chris Sleight explores how automation could ease burnout, meet younger staff’s expectations and give health professionals more time with patients. Read his perspective on automation as a workforce retention strategy. 👇 buff.ly/ZjYrWxU #NHS #HealthTech #Automation

Anthropic has acquired Mithril Medicine, a one-person start-up developing treatments for two rare forms of muscular dystrophy. 🔗 Full story: buff.ly/iSQjVHw #DrugDiscovery #ArtificialIntelligence #Biotechnology #RareDisease #PharmaInnovation

How do we measure the full impact of a rare disease on patients and families? A new study will explore quality of life, caregiving, education, employment and financial pressures, building evidence while potential therapies are still in development. Orlando Agrippa explores why this work matters and how Sanius Health and Kielo Research are helping connect lived experience with evidence that can inform future treatment and access decisions. Read more below 👇 buff.ly/lKxKaYN #RareDisease #SYNGAP1 #PatientCentredResearch

Leeds medtech spinout adsilico has raised £10m to expand its AI-powered virtual patient technology for testing medical devices. 🔗 Full story: buff.ly/vZbtJYi #Medtech #HealthcareAI #VirtualPatients #MedicalDevices #HealthTechInvestment

Preventive health start-up Cent has raised US$15m and acquired an AI radiology reporting platform to support its expansion. 🔗 Full story: buff.ly/o1Jpzke #HealthTech #RadiologyAI #MedicalImaging #HealthcareInvestment #PreventiveHealth

UK biotech venture capital investment rose 44 per cent to £270m in the third quarter, putting the sector on course for its strongest funding year since 2021. 🔗 Full story: buff.ly/gDcaNnv #UKBiotech #LifeSciences #BiotechInvestment #VentureCapital #HealthcareInnovation

AI medical device regulation is changing, but are NHS trusts ready? With the UK government shifting towards greater oversight of AI medical devices throughout their lifecycle, hospitals will need to think beyond initial approval. Rafael Patron, president of AIPIA's Scientific-Technical Committee, explores the practical steps NHS trusts should take now, from monitoring performance to managing model updates and ensuring patient safety. Read the full blog 👇 buff.ly/gHFDvb0 #HealthTech #HealthcareAI #NHS #MedicalDevices #AIRegulation

Bolt Biotherapeutics has acquired Prana Therapies and announced US$120m in private financing to advance treatments for inflammatory diseases. 🔗 Full story: buff.ly/oKykEzn #Biotechnology #DrugDevelopment #Immunology #Biopharma #HealthcareInvestment

What happens when an NHS AI tool changes but the staff using it aren't prepared? As AI becomes more embedded in healthcare, software updates could introduce new risks if clinicians are unaware of changes in how systems behave. Behavioural scientist Gleb Tsipursky explores why NHS organisations should introduce staff rehearsals following significant AI updates to protect patient safety and maintain trust in technology. 🔗 Read the full blog: buff.ly/8gKXO8Q #HealthcareAI #NHS #PatientSafety #HealthTech

India is emerging as a center of scientific innovation, commercial growth and global capability. For US and European life sciences companies, the opportunity extends beyond entering a growing market to helping shape the future of health innovation for middle-income nations. 🔗 Full story: buff.ly/6iaRuIe #LifeSciences #HealthcareInnovation #India #Biotechnology #GlobalHealth

Global law firm McDermott Will & Schulte advised TFP Fertility Group (TFP), a leading fertility care provider in the UK and Poland backed by Amulet Capital Partners, on its acquisition of Manchester Fertility Group. 🔗 Full story: buff.ly/gdsvHtY #FertilityCare #HealthcareAcquisitions #PrivateEquity #ReproductiveHealth #UKHealthcare

Coherence Neuro has raised US$45m in Series A funding to advance a long-term human trial of its implantable brain cancer technology. 🔗 Full story: buff.ly/fbuwAlR #BrainCancer #Neurotechnology #Medtech #HealthTech #SeriesAFunding

UK Biobank is working with three companies to map the human immune system using blood samples from 80,000 participants. 🔗 Full story:vhttps://buff.ly/vxfhTEk #UKBiobank #ImmuneSystem #Immunology #LifeSciences #HealthTech

Merck KGaA plans to acquire UK-based Silence Therapeutics for about US$1.3bn in an all-cash deal that will expand its precision medicine pipeline and RNA-targeting technology. 🔗 Full story: buff.ly/A5sxO98 #Merck #SilenceTherapeutics #Biotech #DrugDevelopment #PharmaAcquisition

Blood proteins may help identify men at risk of prostate cancer more than 15 years before diagnosis, according to new research. 🔗 Full story: buff.ly/oCoqLrb #ProstateCancer #CancerResearch #BloodTests #EarlyDetection #HealthTech